Clinical Trial Update: Zalutumumab With or Without Irinotecan Chemotherapy in Cetuximab-Refractory Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for zalutumumab with or without irinotecan in cetuximab-refractory colorectal cancer; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• Zalutumumab (zalutumumab)

Snippet

Sponsor: Genmab | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2011-12-23